Skip to main content

Table 1 Study schedule

From: Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

  1. *only those women of reproductive potential
  2. **Confirm documented disease status (CR, PR, SD, PD or ND)
  3. ***optional or if blood being taken as part of routine care
  4. ^ including cannabis and complimentary medicine use
  5. #eligibility data to be used as baseline as long as within 3 days of each oth
\